State-of-the-Science Conference on Active Surveillance for Prostate Cancer Slated for December || NCI Cancer Bulletin for November 15, 2011 - National Cancer Institute

State-of-the-Science Conference on Active Surveillance for Prostate Cancer Slated for December

On December 5–7, NCI and the NIH Office of Medical Applications of Research (OMAR) will convene a state-of-the-science conference on active surveillance for men with localized prostate cancer. The conference will take place at Natcher Conference Center on the NIH campus and will address the following key questions:   

• How have the patient population and the natural history of prostate cancer diagnosed in the United States changed in the last 30 years?
• How are active surveillance and other observational strategies defined?
• What factors affect the offer of, acceptance of, and adherence to active surveillance?
• What short- and long-term health outcomes have patients with localized prostate cancer experienced with active surveillance versus immediate treatment with curative intent?
• What aspects of active surveillance (or watchful waiting) in localized prostate cancer need further research?

Invited experts will present information pertinent to these questions, and OMAR will prepare a systematic literature review. Conference attendees will have the opportunity to ask questions and provide statements during open discussion periods. After weighing the scientific evidence, an unbiased, independent panel will prepare and present a consensus statement addressing the key conference questions.

The conference is free and open to the public, but advance registration is recommended. For more information and to register, visit the conference website.
NCI Cancer Bulletin for November 15, 2011 - National Cancer Institute